Foamix Investigational Site # 242 — Bay City, Michigan

Foamix Investigational Site # 242 is a clinical research site located in Bay City, Michigan, United States 48706.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Foamix Investigational Site # 242 has participated in 1 clinical trials.

Therapeutic areas: Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bay City

Browse all research sites in Michigan · View every site in Bay City

• McLaren Bay Region Hospital
• Michigan State University/Bay Regional Medical Center
• Great Lakes Research Group
• McLaren Cancer Institute-Bay City
• Bay Regional Medical Center
• Research Site
• McLaren-Bay Region
• GSK Investigational Site
• Karmanos Cancer Institute at McLaren Bay Region
• Clinical Trial Site
• Dermavant Investigative Site
• McLaren Bay

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site # 242?

Foamix Investigational Site # 242 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site # 242 conducted?

Foamix Investigational Site # 242 has 1 clinical trials on record. Their work covers Papulopustular Rosacea.

Is Foamix Investigational Site # 242 accredited by Crixeo Clinical Trials?

Foamix Investigational Site # 242 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site # 242?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.